- Home
- BBAR vs HRMY Comparison
BBAR vs HRMY Comparison
Compare BBAR & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBAR
- HRMY
- Stock Information
- Founded
- BBAR 1886
- HRMY 2017
- Country
- BBAR Argentina
- HRMY United States
- Employees
- BBAR N/A
- HRMY N/A
- Industry
- BBAR Commercial Banks
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- BBAR Finance
- HRMY Health Care
- Exchange
- BBAR Nasdaq
- HRMY Nasdaq
- Market Cap
- BBAR 2.5B
- HRMY 2.1B
- IPO Year
- BBAR N/A
- HRMY 2020
- Fundamental
- Price
- BBAR $12.35
- HRMY $35.99
- Analyst Decision
- BBAR Buy
- HRMY Strong Buy
- Analyst Count
- BBAR 1
- HRMY 9
- Target Price
- BBAR $27.00
- HRMY $55.33
- AVG Volume (30 Days)
- BBAR 715.8K
- HRMY 531.4K
- Earning Date
- BBAR 08-20-2025
- HRMY 10-28-2025
- Dividend Yield
- BBAR 0.18%
- HRMY N/A
- EPS Growth
- BBAR N/A
- HRMY 58.41
- EPS
- BBAR 0.38
- HRMY 3.10
- Revenue
- BBAR $1,945,235,030.00
- HRMY $772,527,000.00
- Revenue This Year
- BBAR N/A
- HRMY $20.09
- Revenue Next Year
- BBAR $23.38
- HRMY $16.74
- P/E Ratio
- BBAR $10.97
- HRMY $11.61
- Revenue Growth
- BBAR N/A
- HRMY 17.74
- 52 Week Low
- BBAR $10.06
- HRMY $26.47
- 52 Week High
- BBAR $25.01
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- BBAR 30.55
- HRMY 47.09
- Support Level
- BBAR $11.58
- HRMY $36.50
- Resistance Level
- BBAR $12.79
- HRMY $38.28
- Average True Range (ATR)
- BBAR 0.79
- HRMY 0.95
- MACD
- BBAR -0.16
- HRMY -0.17
- Stochastic Oscillator
- BBAR 15.87
- HRMY 9.84
About BBAR Banco BBVA Argentina S.A. ADS
Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.